- $27 million: Largest personal donation ever received by MCW's Cancer Center.
- 5-year survival rates for choroid plexus carcinoma: Between 40% and 60%.
- $150 million facility: The Michels Center for Cancer Discovery opened in 2025, housing over 300 scientists.
Experts would likely conclude that this transformative donation represents a pivotal step toward advancing precision oncology, fostering health equity, and positioning Wisconsin as a leader in cancer research.
A Family’s Fight, A City’s Future: A $27M Bet on a Cancer-Free Wisconsin
MILWAUKEE, June 22, 2026 –– The Medical College of Wisconsin (MCW) today announced a landmark $27 million gift from Tim and Barbara Michels and their family foundation, the largest personal donation ever received by its Cancer Center. The investment, born from a deeply personal family battle with the disease, will name MCW’s new state-of-the-art research facility the “Medical College of Wisconsin Michels Center for Cancer Discovery” and aims to fundamentally reshape the landscape of cancer research and care throughout the state.
This is not merely a story of philanthropy; it is a story of how private capital, fueled by personal experience, can intersect with institutional ambition to address systemic challenges in public health. The donation is a multi-pronged investment designed to attract world-class scientists, accelerate the development of personalized therapies, and, critically, extend the reach of advanced medicine to Wisconsin’s most vulnerable communities.
From Personal Pain to Public Promise
The driving force behind this monumental gift is a story of fear, hope, and survival. In 2012, the Michels family’s world was upended when their 11-year-old daughter, Sophie, was diagnosed with choroid plexus carcinoma, a rare and highly aggressive pediatric brain tumor. With five-year survival rates hovering between 40% and 60%, the diagnosis plunged the family into the uncertainty that countless others face.
Sophie’s treatment journey, which included three surgeries and multiple rounds of chemotherapy, unfolded at MCW and its affiliate, Children’s Wisconsin. The family credits her recovery to the institution’s “renowned precision oncology expertise and research-driven care.” Nearly 15 years later, Sophie is thriving—a living testament to the power of localized, cutting-edge medical science. This experience forged an unbreakable bond between the family and the institution, and it crystallized a new mission.
“Our family knows firsthand what it means to face a rare cancer diagnosis with few treatment options, and even fewer answers,” Tim and Barbara Michels stated. “We're investing in the Medical College of Wisconsin because we believe in their extraordinary scientists and physicians to turn today's breakthrough cancer discoveries into tomorrow's cures. No family should have to face cancer without hope, and that's exactly what this gift is about — giving more families hope and giving cancer researchers the resources to deliver on it.”
This commitment is not new. The $27 million gift builds upon a previous $15 million donation from the family in 2022, which established the Michels Rare Cancers Research Laboratories. The continued investment underscores a long-term strategic partnership aimed at building a self-sustaining ecosystem of cancer innovation in Wisconsin.
Fueling a New Frontier in Precision Oncology
The Michels’ investment arrives at a pivotal moment for the Medical College of Wisconsin. The newly named Michels Center for Cancer Discovery, a five-story, $150 million facility that opened in 2025, is the physical embodiment of MCW’s ambition. It is the only research facility in eastern Wisconsin exclusively dedicated to cancer, designed to consolidate over 300 scientists and staff into collaborative “scientific neighborhoods.”
This gift acts as high-octane fuel for that engine. The funds are earmarked to attract preeminent investigators in precision oncology, enhance the technological infrastructure needed to translate discoveries into therapies, and train the next generation of cancer scientists. This includes bolstering the center’s “BioHub,” a biotech incubator designed to spin off faculty-led startups, creating a cycle of innovation where commercial success can be reinvested into future research.
The investment is a critical component of MCW’s quest to achieve National Cancer Institute (NCI) designation. Milwaukee currently holds the distinction of being the largest metropolitan area in the U.S. without an NCI-designated cancer center, a status that limits access to federal funding and prestigious clinical trials. Achieving this designation would not only elevate MCW’s national standing but also serve as a powerful magnet for talent and economic development in the region.
“We're grateful to the Michels family for their remarkable kindness,” said John R. Raymond, Sr., MD, MCW's president and CEO. “The philanthropic leadership they've demonstrated will only further elevate the Medical College of Wisconsin as a burgeoning hub for exceptional medical research and a premier destination for leading cancer investigators and clinicians.”
Closing the Care Gap Across Wisconsin
Perhaps the most socially significant aspect of the Michels’ gift is its explicit focus on health equity. A key objective is to expand access to precision oncology-driven prevention and early detection, with a particular emphasis on rural and medically underserved communities.
This is a direct response to a pressing public health crisis. Wisconsin’s overall cancer rates are higher than the national average, and the burden is not shared equally. The state has some of the nation’s largest racial disparities in cancer mortality, particularly between its Black and white residents for lung and breast cancer. Furthermore, rural populations often face significant barriers to screening and specialized care.
MCW’s Cancer Center already operates an extensive Community Outreach and Engagement (COE) office, serving a 29-county region that is home to over half the state’s population, including 40% of its rural residents. The COE office runs programs to improve clinical trial access, deploy patient navigators, and use community advocates to promote early detection.
The new funding will empower MCW to scale these efforts by integrating its most advanced research with its community outreach. For example, developing more accessible screening methods like liquid biopsies—a key research focus at MCW—could revolutionize early detection in remote areas. By arming its outreach teams with the fruits of the Michels Center for Cancer Discovery, MCW aims to move beyond simply acknowledging health disparities to actively dismantling them, ensuring that a patient’s zip code does not determine their access to life-saving innovation.
